workshop
antimicrobi
resist
environ
assess
manag
effect
anthropogen
activ
held
march
canada
focus
anti
biotic
resist
environ
approach
assess
manag
effect
anthropogen
activ
human
health
concern
identifi
environment
deriv
antibioticresist
bacteria
arb
may
advers
affect
human
health
eg
reduc
efficaci
clinic
anti
biotic
use
seriou
prolong
infect
either
direct
exposur
patient
antibiot
resist
pathogen
exposur
patient
resist
determin
subsequ
horizont
gene
transfer
hgt
bacteri
pathogen
within
human
host
conceptu
figur
arb
hazard
develop
environ
result
direct
uptak
antibioticresist
gene
arg
via
variou
mechan
eg
mobil
genet
element
plasmid
integron
gene
cassett
transposon
andor
prolifer
environment
select
caus
anti
biotic
coselect
agent
biocid
toxic
metal
nanomateri
stressor
qiu
et
al
taylor
et
al
gene
mutat
gill
stoke
depend
presenc
recipi
bacteria
process
gener
either
environment
antibioticresist
bacteria
earb
pathogen
antibioticresist
parb
figur
human
health
risk
assess
hhra
process
use
estim
natur
probabl
advers
health
effect
human
may
expos
hazard
contamin
environment
media
futur
us
environment
protect
agenc
epa
review
focu
appli
hhra
risk
infec
tion
pathogen
arb
increas
caus
morbid
mor
taliti
particularli
develop
region
background
recent
environ
clearli
implic
risk
antibiot
resist
clinic
outcom
date
document
approach
formal
assess
risk
object
examin
possibl
approach
sought
identifi
research
need
enabl
human
health
risk
assess
hhra
focu
role
environ
failur
anti
biotic
treatment
caus
antibioticresist
pathogen
method
author
particip
workshop
held
march
canada
defin
scope
object
environment
assess
antibioticresist
risk
human
health
focus
key
element
environmentalresistancedevelop
hot
spot
exposur
assess
unrel
food
dose
respons
character
risk
may
improv
antibioticresist
manag
option
discuss
variou
novel
aspect
tradit
risk
assess
identifi
enabl
assess
environment
antibiot
resist
includ
account
ad
select
pressur
environment
resistom
time
allow
develop
antibioticresist
bacteria
arb
b
identifi
describ
rate
horizont
gene
transfer
hgt
relev
environment
hot
spot
compart
c
modifi
tradit
doserespons
approach
address
dose
arb
variou
health
outcom
pathway
conclus
propos
environment
aspect
antibioticresist
develop
includ
process
hhra
address
arb
limit
avail
data
multicriteria
decis
analysi
approach
would
use
way
undertak
hhra
environment
antibiot
resist
inform
risk
manag
citat
ashbolt
nj
backhau
borriello
p
brandt
antimicrobi
resist
micro
organ
abil
mul
tipli
persist
presenc
increas
level
anti
microbi
agent
compar
suscept
counter
part
speci
review
limit
resist
group
micro
organ
bacteria
therefor
anti
biotic
resist
area
term
antibiot
use
synonym
antibacteri
import
understand
contribut
environ
develop
resist
human
anim
pathogen
therapeut
resist
infect
may
lead
longer
ho
pital
longer
treatment
time
failur
treatment
therapi
need
treatment
toxic
costli
antibiot
well
increas
likelihood
death
vast
amount
work
taken
understand
contribut
role
play
hospit
commun
set
dissemin
mainten
arb
infect
human
particular
area
focu
term
exposur
commun
set
anti
biotic
use
livestock
produc
tion
presenc
earb
parb
food
anim
origin
codex
alimentariu
commiss
establish
food
agricultur
organ
unit
nation
fao
world
health
organ
harmon
intern
food
standard
guidelin
code
practic
protect
health
con
sumer
ensur
fair
trade
practic
food
trade
releas
guidelin
process
methodolog
appli
risk
anali
si
method
foodborn
anti
microbi
resi
tanc
relat
use
anti
microbi
veterinari
medicin
agricultur
codex
alimentariu
commiss
sourc
anti
biotic
anti
microbi
environ
human
sewag
dolejska
et
al
intens
ani
mal
husbandri
wast
manu
factur
pharmaceut
larsson
et
al
environment
consequ
use
releas
anti
biotic
variou
sourc
hgt
antibioticresist
gene
arg
indigen
environment
pathogen
bacteria
resist
determin
et
al
chaga
et
al
chen
et
al
cum
et
al
forsberg
et
al
gao
et
al
qiu
et
al
yet
quanti
fie
global
concern
finley
et
al
genet
element
encod
abil
micro
organ
withstand
effect
anti
microbi
agent
locat
either
chromosom
extra
chromosom
may
associ
mobil
genet
element
pla
mid
integron
gene
cassett
transpo
son
therebi
enabl
horizont
vertic
transmiss
resist
previous
suscept
strain
hhra
point
view
emerg
arb
sourc
drink
water
de
boeck
et
al
isozumi
et
al
shi
et
al
highlight
need
place
emerg
environment
risk
perspect
yet
assess
ing
rang
environment
contribu
tion
anti
biotic
resist
may
complic
lack
quantit
data
also
need
coordin
effort
across
differ
agenc
may
jurisdict
environment
risk
versu
human
anim
health
key
consider
arb
develop
ment
environ
resist
gene
present
due
natur
occur
renc
dcosta
et
al
use
anti
microbi
crop
anim
human
provid
continu
entri
anti
biotic
environ
along
po
sibl
novel
gene
arb
summari
fate
transport
persist
antibiot
resist
gene
land
applic
wast
food
anim
receiv
antibiot
follow
outflow
surfac
water
sewag
treatment
emphas
need
better
understand
environ
mental
mechan
genet
select
gene
acquisit
well
dynam
resist
gene
resistom
bact
rial
host
cheesanford
et
al
crtryn
exampl
presenc
anti
biotic
residu
water
pharma
ceuti
cal
manufactur
certain
part
world
fick
et
al
pond
receiv
intens
anim
wast
barkovskii
et
al
aqua
cultur
water
shah
et
al
sewag
outfal
dolejska
et
al
import
sourc
among
other
lead
pre
enc
arg
surfac
water
particu
lar
compar
high
concentr
anti
biotic
found
effluent
pharma
ceuti
cal
product
plant
asso
ciat
increas
presenc
arg
surfac
water
kristiansson
et
al
li
et
al
li
et
al
recent
sequenc
ident
arg
divers
set
clinic
pathogen
common
soil
bact
ria
forsberg
et
al
highlight
potenti
environ
mental
hgt
earb
parb
despit
concern
risk
assess
ment
evalu
combin
impact
anti
biotic
arg
arb
environ
ment
human
anim
health
keen
montfort
recent
epidemiolog
stud
i
includ
evalu
arb
drink
ing
water
suscept
commens
escherichia
coli
household
member
exampl
coleman
et
al
report
water
along
factor
directli
relat
local
environ
account
presenc
resist
e
coli
human
mani
studi
nativ
bacteria
drink
water
system
shown
accumul
arg
vazmoreira
et
al
addit
address
environment
risk
aris
develop
anti
biotic
resist
also
consid
develop
enrich
parb
low
probabl
high
impact
onetim
event
type
risk
exceedingli
rare
event
result
transfer
novel
clinic
import
bacteria
resist
gene
harmless
environment
bacterium
pathogen
need
happen
human
recipi
novel
parb
unlik
emerg
sar
sever
acut
respira
tori
syndrom
similar
virus
hindsight
risk
factor
well
stood
swift
et
al
condit
onetim
event
could
occur
rang
normal
habitat
develop
resi
tant
bacteriumgen
possibl
spread
human
around
world
seen
spread
new
delhi
resist
wilson
chen
promot
use
anti
biotic
although
seem
difficult
quantifi
probabl
rare
event
includ
assess
probabl
happen
consid
abl
valu
tri
identifi
risk
factor
point
critic
environ
hgt
occur
identifi
pharmaceut
exposur
level
could
caus
select
pre
sure
henc
increas
abund
given
gene
critic
hgt
event
may
move
quantit
kind
hhra
overal
goal
workshop
anti
microbi
resist
environ
assess
manag
effect
anthropogen
activ
identifi
signific
arb
within
environ
map
complex
involv
order
identifi
research
gap
provid
statement
level
scientif
understand
variou
arb
issu
broad
rang
intern
deleg
includ
aca
demic
govern
regul
industri
mem
ber
clinician
discuss
variou
issu
focu
review
aros
discuss
improv
understand
human
health
risksin
addit
epidemiolog
studiesbi
develop
hhra
explor
potenti
risk
inform
risk
manag
ment
end
goal
assess
depend
context
eg
research
regul
provid
gener
approach
take
hhra
environment
arb
adapt
user
interest
conceptu
figur
given
mani
uncertainti
also
highlight
identifi
research
gap
understand
go
relev
inter
nation
activ
type
anti
biotic
use
provid
good
start
point
aid
frame
risk
assess
arb
codex
alimentariu
commiss
describ
eight
principl
specif
risk
analysi
foodborn
anti
microbi
resist
sever
gener
applic
hhra
environ
mental
arb
exampl
includ
recommend
joint
faowho
oie
expert
meet
critic
import
antimicrobi
food
agricultur
organ
unit
nationsworld
health
organizationworld
organis
anim
health
advisori
group
integr
surveil
antimicrobi
resist
provid
inform
set
prioriti
anti
biotic
human
risk
assess
ment
note
sig
nific
nation
region
differ
anti
biotic
use
resist
pattern
human
exposur
pathway
gener
risk
assess
frame
identifi
risk
manag
goal
assess
inform
need
possibl
manag
option
enabl
evalu
manag
success
consensu
workshop
particip
manag
ment
could
best
appli
point
anti
biotic
manufactur
use
agricultur
oper
includ
aquacultur
wastewat
treat
ment
plant
pruden
et
al
assess
rel
impact
manag
particular
part
system
hamper
lack
knowledg
rel
import
part
system
overal
risk
recent
state
amr
complex
problem
driven
mani
inter
connect
factor
singl
isol
intervent
littl
impact
coordi
nate
action
requir
henc
start
ing
point
assess
environment
anti
bioticresist
risk
intend
aid
risk
manag
theo
retic
risk
assess
pathway
base
local
surveil
data
occurr
type
anti
biotic
use
human
medi
cine
crop
product
anim
husbandri
companion
anim
b
infor
mation
arg
arb
variou
environment
compart
particular
soil
aquat
system
includ
drink
water
c
relat
diseas
inform
assess
amend
discuss
relev
stakehold
requir
extens
risk
commun
could
form
part
multi
criteria
decis
analysi
mcda
approach
discuss
detail
result
workshop
pruden
et
al
also
advoc
coupl
environ
mental
manag
ment
mitig
plan
tar
gete
surveil
monitor
effort
order
judg
rel
impact
success
intervent
undertak
use
human
health
risk
assess
detail
requir
quantit
measur
thu
key
issu
experi
mental
model
approach
use
deriv
estim
furthermor
haz
ard
concentr
time
environ
mental
compartmentdepend
aspect
also
taken
account
first
current
understand
nonmut
deriv
antibiot
resist
develop
environment
bacteria
includ
pathogen
may
activ
grow
outsid
host
develop
earbparb
figur
pro
cess
select
pressur
ie
pre
enc
anti
biotic
antibioticresist
determin
must
maintain
time
presenc
arg
exist
parb
releas
environ
sur
vival
environment
media
critic
factor
howev
exact
mechan
quantit
relationship
select
pressur
arb
develop
yet
elucid
may
differ
depend
anti
biotic
bacteri
spe
cie
resist
mechan
involv
case
select
pressur
remov
abund
antibioticresist
arb
may
reduc
extinct
hugh
cottel
et
al
even
small
number
arb
com
muniti
level
repres
reservoir
arg
horizont
transfer
pressur
reap
pli
seem
inevit
arb
eventu
develop
anti
biotic
levi
marshal
key
manag
ment
aim
seem
delay
confin
develop
much
possibl
second
robust
quantit
risk
assess
ment
requir
rate
hgt
andor
gene
mutat
relev
compart
figur
process
describ
differ
combin
donat
earb
strain
receiv
parb
strain
lack
quantit
estim
mutationhgt
arg
major
data
gap
third
tradit
microbi
risk
assess
ment
doserespons
approach
figur
process
could
use
address
like
hood
infect
codex
alimentariu
commiss
us
epa
us
depart
agriculturefood
safeti
inspect
servic
usdafsi
novel
aspect
requir
herein
addit
hgt
arb
selectionwould
address
quantit
doserespons
relat
ship
earb
presenc
sensit
pathogen
human
figur
pro
cess
importantli
key
differ
tradit
hhra
undertaken
jurisdict
essenti
includ
environment
process
fulli
assess
human
risk
associ
anti
biotic
resist
therefor
type
inform
document
human
healthori
risk
assess
environment
arb
includ
follow
adapt
codex
alimentariu
commiss
clinic
environment
surveil
program
anti
biotic
arb
determin
focu
region
data
volum
number
septemb
environment
health
perspect
report
type
use
anti
biotic
human
medicin
crop
commerci
companion
anim
well
global
crop
food
anim
produc
epidemiolog
investig
outbreak
sporad
case
associ
arb
includ
clinic
studi
occurr
frequenc
sever
arb
infect
identif
select
pressur
time
dose
selectingcoselect
agent
requir
select
resist
differ
ent
environ
subsequ
hgt
humanrelev
bacteria
base
report
describ
frequenc
hgt
uptak
arg
environment
bac
teria
includ
environment
pathogen
previous
identifi
hot
spot
human
laboratori
andor
field
animalcrop
trial
address
link
anti
biotic
use
resist
particularli
region
data
investig
characterist
arb
determin
ex
situ
situ
studi
link
resist
viru
lenc
andor
ecolog
fit
eg
surviv
abil
adapt
arb
studi
environment
fate
anti
biotic
residu
water
soil
bioavail
associ
select
arb
given
environment
com
partment
anim
human
host
result
ing
parb
exist
risk
assess
arb
relat
pathogen
summari
mani
sourc
data
requir
undertak
human
health
risk
assess
environ
mental
arb
much
data
may
sever
limit
particularli
quantit
assess
thu
final
risk
assess
report
emphas
import
evid
trail
weight
evid
find
furthermor
model
construct
previous
unus
data
set
consid
ere
model
verif
possibl
human
health
risk
assess
anti
biotic
environ
build
tradit
chemic
risk
assess
nation
research
council
start
exampl
accept
abl
daili
intak
adi
base
resist
data
vich
steer
committe
correspond
metric
environ
mental
anti
biotic
concentr
could
develop
base
concept
minimum
select
concentr
msc
gullberg
et
al
defin
minimum
concentr
anti
biotic
agent
select
resist
unlik
tradit
chemic
risk
assess
ment
approach
msc
assay
would
necessari
address
human
health
effect
aris
arg
resist
determin
give
rise
arb
includ
resist
associ
mutat
figur
process
absenc
specif
data
msc
assay
could
inform
risk
ass
sor
select
concentr
pharma
ceutic
complex
mixtur
compound
matrix
choic
allow
descript
threshold
signific
arb
develop
pathogen
risk
may
evalu
microbi
risk
assess
mra
struc
ture
systemat
sciencebas
approach
build
chemic
risk
assess
paradigm
mra
involv
problem
mulat
describ
hazard
risk
set
pathway
b
exposur
assess
hazard
arb
arg
c
doserespons
assess
ment
quantifi
relationship
hazard
dose
parb
infect
human
figur
process
com
binat
procedur
character
risk
variou
pathway
exposur
pathogen
identifi
assess
mra
use
qualit
quantit
evalu
ate
level
exposur
subsequ
risk
human
health
microbiolog
haz
ard
context
anti
bioticresist
micro
organ
environment
mra
infanc
need
address
resist
bac
teria
andor
determin
mra
origin
develop
fecal
pathogen
hazard
food
water
ilsi
intern
life
scienc
institut
recent
modif
includ
biofilmassoci
environment
pathogen
legionella
pneumophila
schoen
ashbolt
human
pathogen
grow
envi
ronment
may
becom
parb
figur
process
mani
infect
compromis
individu
gener
term
opportunist
pathogen
past
year
mra
larg
evolv
input
inter
nation
food
safeti
commun
wellrecogn
accept
approach
food
safeti
risk
analysi
codex
alimentariu
adopt
principl
guidelin
conduct
microbiolog
risk
assess
codex
alimentariu
commiss
recent
codex
alimentariu
guidelin
risk
analysi
foodborn
antimicrobi
resist
includ
eight
principl
codex
alimentariu
commiss
unit
state
mra
guidelin
food
water
us
epa
usdafsi
continu
use
fourstep
framework
origin
describ
chemic
risk
assess
sever
arb
risk
assess
publish
review
recent
year
geenen
et
al
mcewen
snari
et
al
howev
nearli
studi
focu
foodborn
transmi
sion
human
health
risk
assess
deal
arb
transmiss
via
variou
environ
mental
rout
direct
contact
arg
spars
exampl
geenen
et
al
studi
extendedspectrum
betalactamas
esbl
produc
bacteria
identifi
follow
risk
factor
previou
admiss
healthcar
facil
use
anti
microbi
drug
travel
highendem
countri
esbl
posit
famili
member
author
con
clude
environ
mental
risk
assess
would
help
address
problem
esblproduc
bacteria
none
perform
hazard
identif
hazard
charac
teriz
unfortun
unawar
data
quantit
link
arg
uptak
human
health
effect
figur
process
data
exist
rapidli
improv
qualiti
howev
presenc
arg
within
variou
environ
mental
compart
allen
et
al
cum
et
al
ham
et
al
specif
clinic
rele
vant
resist
gene
within
soil
forsberg
et
al
figur
process
precursor
lead
develop
ment
arb
hazard
includ
arg
mecha
nism
mobil
gene
anti
biotic
coselect
agent
qiu
et
al
taylor
et
al
along
gene
mutat
gill
stoke
depend
presenc
recipi
bac
teria
process
gener
either
earb
parb
figur
process
regard
numer
paramet
rele
vant
individu
environment
compart
ment
awar
avail
comprehens
data
anti
biotic
resist
develop
anti
biotic
coselect
ing
agent
b
flow
arg
resistom
acquisit
element
eg
integron
nativ
environment
compart
bacteria
c
like
rang
rate
horizont
vertic
gene
transfer
within
environ
mental
compart
nonetheless
factor
consid
import
includ
rang
potenti
pathway
involv
releas
anti
biotic
arg
arb
amplifi
ing
environment
compart
rhizospher
bulk
soil
compost
biofilm
wastewat
lagoon
river
sedi
ment
aqua
cultur
plant
bird
wildlif
respect
anti
biotic
gener
follow
inform
requir
aid
haz
ard
character
list
local
anti
biotic
class
concern
b
known
environment
fate
c
may
accumul
particular
environment
compart
eg
rhizospher
gener
soil
compost
biofilm
wastewat
lagoon
river
sediment
aquacultur
plant
bird
wildlif
farm
anim
companion
ani
mal
select
arb
figur
process
depend
type
situ
bio
avail
selectingcoselect
agent
abund
bacteri
host
abun
danc
ar
determin
select
arb
modul
nutrit
statu
member
rele
vant
bacteri
commun
high
meta
bolic
activ
high
cell
densiti
promot
bacteri
commun
success
hgt
brandt
et
al
et
al
contrast
hgt
rel
independ
anti
bioticsalthough
anti
biotic
arb
may
cotransport
chen
et
al
increas
hgt
rate
thought
occur
stress
bacteria
exampl
integras
express
upregul
increas
bacteri
so
respons
process
dna
repair
presenc
certain
anti
biotic
guerin
et
al
although
quantit
data
describ
develop
parb
environ
lack
ampl
evid
exist
co
uptak
antibioticsensit
pathogen
presenc
anti
biotic
arg
plasmid
metal
resist
andor
carbon
util
gene
knapp
et
al
laverd
gomez
et
al
demon
strate
vitro
disinfectantnanomateri
qiu
et
al
soumet
et
al
spatial
distribut
organ
opportun
close
proxim
may
also
affect
gene
transfer
result
inher
ent
patchi
ness
soil
structur
presenc
substrat
forth
consid
gene
transfer
rate
may
hot
spot
activ
iti
exampl
evid
hgt
clinic
rele
vant
resist
gene
bacteria
manureimpact
soil
forsberg
et
al
associ
rhi
zospher
organicrich
condi
tion
pontiroli
et
al
addit
select
pressur
subsequ
prolifera
tion
earb
may
higher
hot
spot
environ
brandt
et
al
li
et
al
therefor
import
reco
gnize
like
zone
high
activ
prob
lem
formul
hazard
character
stage
risk
assess
use
sampl
identifi
situ
exchang
rate
exampl
marker
anthropogen
impact
potenti
predict
impact
mobil
resistom
class
integron
could
use
abil
integr
gene
cassett
confer
wide
rang
anti
biotic
biocid
resist
gaze
et
al
semipristin
soil
preval
may
two
three
order
magnitud
lower
impact
soil
sedi
ment
vs
respect
gaze
et
al
zhu
et
al
addit
huge
divers
earb
hazard
sever
pathogen
could
evalu
microbi
risk
assess
ment
foodborn
waterborn
fecal
pathogen
repres
campylobact
jejuni
salmonella
enterica
variou
patho
genic
e
coli
b
environ
mental
pathogen
respiratori
skin
wound
pathogen
repres
legionella
pneumophila
staphylococcu
aureu
pseudomona
aeruginosa
fecal
environment
pathogen
well
known
abl
acquir
arg
thu
given
data
environmen
tal
hgt
rate
could
use
refer
enc
pathogen
microbi
risk
assess
howev
much
problemat
risk
assessmentand
current
limit
factori
rate
indigen
bacteria
transfer
resist
pathogen
within
environment
compart
within
humananim
host
figur
pro
cess
method
model
experi
mental
deriv
relev
inform
environment
issu
discuss
environment
exposur
assess
data
hgt
within
human
gastro
intestin
tract
summar
hunter
et
al
doserespons
relationship
properli
charac
teriz
human
risk
typic
select
hazard
doserespons
health
data
describ
either
determinist
stochast
avail
refer
enc
enter
pathogen
eg
campylobact
jejuni
salmonella
enterica
e
coli
schoen
ashbolt
doserespons
health
data
yet
quantifi
skinwound
refer
pathogen
mena
gerba
rose
haa
howev
note
process
figur
import
differ
arb
need
account
phenomena
associ
select
environment
pressur
develop
arb
ultim
form
human
infect
dose
either
earb
parb
exact
mechan
doserespons
relationship
yet
eluci
date
may
differ
depend
bacteri
speci
resist
mechan
involv
nevertheless
seem
reason
non
compromis
human
expos
parb
fit
publish
doserespons
infect
relationship
eg
deriv
feed
trial
healthi
adult
inform
collect
outbreak
inv
tigat
strain
pathogen
without
antibiot
resist
appear
limit
doserespons
model
describ
probabl
ill
base
condit
probabl
infect
includ
peopl
alreadi
compro
mise
go
anti
biotic
therapi
although
definit
data
parb
pathogen
caus
sever
ill
antimicrobi
suscept
equival
barza
helm
et
al
helm
et
al
traver
barza
may
alway
case
evan
et
al
wassenaar
et
al
clear
exampl
excess
mortal
includ
associ
ate
blood
stream
infect
methicillin
resist
staphylococcu
aureu
mrsa
third
gener
cephalosporinresist
e
coli
particip
european
countri
case
mrsa
associ
excess
death
excess
hospit
day
epi
sode
blood
stream
infect
respons
excess
death
extra
hospit
day
de
kraker
et
al
author
predict
combin
burden
resist
mrsa
like
lead
pre
dict
incid
associ
death
per
inhabit
yet
mani
region
world
predict
less
well
understood
final
step
mra
risk
charac
teriza
tion
integr
output
hazard
identif
hazard
charac
teriz
dose
respons
exposur
assess
intent
gener
overal
estim
risk
estim
may
express
variou
measur
risk
exampl
term
individu
popula
tion
risk
estim
annual
risk
base
exposur
specif
hazard
depend
purpos
risk
assess
risk
character
also
includ
key
scientif
assumpt
use
risk
assess
sourc
variabl
uncer
tainti
scientif
evalua
tion
risk
manag
option
base
conceptu
pro
cess
import
undertak
hhra
arb
figur
element
relat
arb
develop
environment
media
pro
cess
address
hazard
identif
hazard
charac
teriz
focu
describ
import
environment
compart
human
exposur
arb
figur
pro
cess
concentr
environ
mental
factor
anti
biotic
arb
along
fate
transport
point
human
uptak
critic
exposur
assess
particular
human
health
risk
assess
arb
would
impor
tant
selectexpand
individu
pathway
scenario
identifi
critic
environment
compart
human
contact
relev
anti
bioticresist
determin
identi
fie
problem
formul
hazard
character
stage
compart
potenti
concern
includ
soil
environ
receiv
anim
manur
biosolid
compost
lagoon
river
sediment
receiv
wast
water
chen
et
al
tradit
rout
human
exposur
contamin
could
includ
earb
parb
drink
water
recreat
irrig
water
impact
sewag
andor
anti
biotic
volum
number
septemb
environment
health
perspect
product
wastewat
food
air
affect
farm
build
exposur
farm
ani
mal
manur
discuss
pruden
et
al
emerg
import
research
gap
situ
develop
arb
within
biofilm
boehm
et
al
associ
freeliv
protozoa
may
protect
transport
arb
abraham
within
drink
water
system
schwartz
et
al
silva
et
al
latter
rout
could
particularli
problem
atic
hospit
drink
water
system
alreadi
vulner
popul
expos
addit
increas
use
exposur
domest
collect
rainwa
ter
atmospher
fallout
arb
may
seed
household
system
kaushik
et
al
identifi
anti
biotic
concentra
tion
pathogen
densiti
environ
ment
well
possibl
level
rate
arb
gener
environment
compart
rang
fate
transport
model
avail
estim
amount
anti
biotic
pathogen
arb
arg
point
human
contact
figur
pro
cess
model
larg
base
hydro
dynam
pathogenspecif
paramet
account
like
inactiv
predat
soil
aquat
environ
sunlight
inactiva
tion
bradford
et
al
cho
et
al
ferguson
et
al
key
aspect
fate
transport
model
abil
account
inher
vari
abil
system
compon
addit
uncertainti
assess
model
paramet
valu
factor
fate
tran
port
model
use
bayesian
syn
thesi
method
albert
et
al
william
et
al
better
account
param
eter
uncertainti
recent
model
includ
bayesian
learn
algorithm
help
integr
inform
use
meteo
rolog
hydrolog
microbi
explana
tori
variabl
dotto
et
al
motamarri
boccelli
overal
model
also
help
identifi
manag
opportun
mitig
exposur
arb
anti
biotic
import
aspect
describ
path
way
hazard
point
human
exposur
risk
assess
consid
complex
exposur
path
way
associ
environment
arb
risk
larg
uncertainti
input
data
node
along
variou
exposur
path
way
output
would
inevit
difficult
decis
maker
interpret
could
fact
counter
product
thu
merit
consid
decis
analysi
approach
priorit
risk
guid
resourc
alloc
data
collect
activ
facilit
decis
make
although
rang
rank
option
use
weight
select
criteria
cooper
et
al
pire
hald
well
failur
mode
effect
analysi
pillay
wang
overal
area
microbi
risk
assess
consolid
mcda
approach
may
includ
bayesian
algorithm
lienert
et
al
ludwig
et
al
ruzant
et
al
approach
mcda
design
provid
structur
framework
mak
ing
choic
multipl
factor
need
consid
decisionmak
pro
cess
mcda
wellestablish
tool
use
evalu
document
ing
import
assign
differ
fac
tor
rank
risk
lienert
et
al
albeit
heavili
depend
expert
opinion
context
mra
mcda
use
rank
foodborn
microbi
risk
base
multipl
factor
includ
public
health
market
impact
consum
percept
accept
social
sensit
ruzant
et
al
well
priorit
select
inter
vention
reduc
pathogen
exposur
fazil
et
al
exampl
mcda
applic
structur
decis
man
age
eco
toxico
logi
cal
risk
also
report
linkov
et
al
semenzin
et
al
provid
use
mcda
approach
mcda
could
use
exampl
evalu
ate
rank
rel
risk
habi
tat
highli
pollut
anti
biotic
arg
arg
determin
describ
possibl
hot
spot
hgt
develop
ment
arb
mcda
could
appli
evalu
rel
contribut
coselect
ing
agent
eg
deterg
biocid
met
al
nano
materi
variou
sourc
overal
risk
arb
environ
moreov
rang
anti
biotic
consid
ere
environment
concern
mcda
approach
could
use
risk
rank
accord
criteria
base
relev
con
tribut
factor
eg
mobil
resist
determin
genet
element
antibiot
resist
transfer
rate
differ
environ
mental
compart
accumul
level
anti
biotic
environment
compart
environment
fate
transport
expo
sure
point
mcda
process
also
import
identifi
low
probabl
high
impact
onetimeev
type
risk
mcda
techniqu
reli
expert
opinion
often
regard
limi
tation
approach
wellstructur
recogn
elicit
practic
use
order
avoid
introduct
bias
error
subject
score
contrast
one
main
advantag
mcda
tech
niqu
captur
consensu
opin
ion
among
expert
group
relev
criteria
rel
weight
decis
sever
research
gap
need
address
particular
specif
atten
tion
paid
contamin
habitat
hot
spot
anti
biotic
coselect
agent
bacteria
carri
resist
determi
nant
mobil
genet
element
favor
abl
condit
bacteri
growth
activityal
condit
expect
favor
hgtprevail
time
howev
data
current
limit
workshop
particip
evalu
altern
way
possibl
experiment
method
address
data
gap
hhra
relat
process
identifi
figur
assay
determin
msc
process
assay
could
develop
mea
sure
msc
gullberg
et
al
rang
anti
biotic
environment
condit
exampl
assay
could
develop
valid
sandi
clay
soil
differ
sediment
water
type
isogen
pair
model
organ
inocul
matrix
choic
subject
titra
tion
select
agent
suffici
high
dilut
select
sub
inhibitori
concen
tration
assay
develop
environ
mental
matric
key
area
research
need
address
howev
overal
care
need
interpret
ex
situ
studi
extrapol
situ
environment
condi
tion
well
deal
illdefin
hazard
mixtur
environ
process
hot
spot
locat
highlevel
hgt
anti
biotic
resist
develop
may
instanc
includ
aquat
environ
affect
pharma
ceutic
industri
effluent
aqua
cultur
sewag
discharg
well
terrestri
environ
affect
deposit
biosolid
anim
manur
degre
persist
anti
biotic
resist
ie
rate
resist
disappear
without
environ
mental
select
pressur
resist
must
also
consid
risk
assess
depend
fit
ness
cost
resist
howev
fit
cost
within
complex
variabl
environ
ment
difficult
assess
furthermor
standard
method
develop
evalu
environ
mental
select
pre
sure
complex
microbi
commun
sever
experiment
approach
possibl
describ
elsewher
berg
et
al
brandt
et
al
approach
identifi
berg
et
al
brandt
et
al
could
labo
ra
tori
base
assess
potenc
known
compoundsmixtur
appli
field
assess
whether
environ
question
exampl
unknown
mixtur
chemic
hot
spot
defin
critic
exposur
level
therefor
import
hhra
output
aid
manag
ment
activ
like
vari
within
environment
compart
depend
locat
screen
novel
resist
determin
reduc
process
screen
procedur
could
introduc
earli
develop
cycl
novel
anti
biotic
ensur
exist
ing
resist
determin
preval
environment
compart
mark
recipi
strain
could
inocul
environment
matric
eg
soil
biosolid
fecal
slurri
steril
matrix
equiva
lent
neg
control
incub
seed
onto
media
contain
studi
compound
along
select
anti
biotic
recov
mark
recipi
strain
demon
strate
resist
plasmid
entir
genom
recipi
could
clone
small
insert
express
vector
transform
e
coli
host
seed
back
onto
media
contain
studi
compound
way
novel
resist
determin
would
identifi
altern
function
meta
genom
could
use
identifi
novel
resist
determin
meta
genom
dna
allen
et
al
brief
dna
would
extract
environment
sampl
clone
express
vector
tran
form
bacteri
host
e
coli
transform
could
screen
studi
compound
resist
gene
identi
fie
use
transposon
muta
genesi
follow
sequenc
bio
informat
analys
would
allow
detect
novel
resist
determin
may
plasmid
born
may
transfer
pathogen
doserespons
data
need
process
unawar
doserespons
data
repres
combin
arg
recipi
previous
suscept
pathogen
dose
human
anim
diseas
figur
process
contrast
variou
exam
ple
illustr
increas
morbid
mor
taliti
human
expos
parb
describ
doserespons
rela
tionship
henc
exist
publish
doserespons
model
non
resist
pathogen
may
appropri
use
beyond
end
point
infect
doserespons
model
address
peopl
variou
lifestag
need
describ
summar
facilit
parb
risk
assess
also
need
develop
doserespons
inform
sec
ondari
ill
end
point
sequela
result
parb
infect
regard
anti
biotic
concentr
time
exposur
give
rise
select
parb
within
human
couptak
earb
sensit
pathogen
safeti
could
base
effect
concentr
specif
anti
biotic
consider
word
screen
valu
determin
whether
action
warrant
could
deriv
acut
mean
daili
anti
biotic
intak
uncertainti
factor
appli
appropri
futur
research
taken
pathogen
anti
bioticrespons
chang
presenc
specif
anti
biotic
treatment
altern
epidemiolog
data
exist
ing
clone
anti
bioticresist
strain
eg
could
provid
use
data
doserespons
exposur
assess
option
rank
risk
overal
hhra
absenc
fulli
quantit
data
undertak
hhra
riskrank
approach
base
exposur
assess
model
could
adopt
develop
inform
alloc
resourc
data
gener
part
hhra
arb
ever
et
al
present
one
approach
context
food
safeti
estim
rel
contribut
campylobact
spp
sourc
transmi
sion
rout
exposur
per
personday
netherland
studi
includ
transmi
sion
rout
relat
direct
contact
anim
ingest
food
water
result
rank
signific
sourc
exposur
although
studi
focus
foodborn
transmiss
rout
deal
anti
bioticresist
campylobact
strain
similar
approach
could
appli
estim
human
exposur
arb
hazard
use
environment
exposur
pathway
describ
ever
et
al
would
requir
data
preval
arg
arb
well
lev
el
anti
biotic
present
exposur
rout
consid
risk
assess
although
approach
probabl
current
fea
sibl
improv
environment
data
select
number
pathogengen
combin
could
develop
futur
altern
approach
captur
knowledg
expert
stakehold
could
develop
bayesian
network
base
expert
knowledg
add
data
becom
avail
describ
campylo
bacter
food
albert
et
al
address
inter
nation
problem
precautionari
approach
use
mani
jurisdict
mani
risk
manag
approach
implement
anti
biotic
resist
issu
worsen
note
relat
risk
manag
paper
result
workshop
pruden
et
al
furthermor
mani
current
risk
manag
scheme
start
process
manag
perspec
tive
delv
quantit
assess
need
order
improv
risk
manag
ment
action
water
safeti
plan
propos
environment
aspect
anti
bioticresist
develop
includ
process
hhra
address
arb
gener
term
mra
appear
suitabl
address
environ
mental
human
health
risk
pose
envi
ronment
releas
anti
biotic
arb
arg
howev
present
still
mani
data
gap
realiz
goal
develop
type
approach
requir
data
mine
previou
epidemiolog
studi
aid
model
develop
param
eter
valid
well
collect
new
inform
particularli
relat
condit
rate
arb
develop
variou
hot
spot
environ
ment
variou
human
health
doserespons
unknown
identifi
review
nearterm
option
like
provid
firstpass
assess
risk
seem
like
base
mcda
approach
could
facilit
bayesian
network
model
mra
model
gain
accept
may
facilit
scenario
test
deter
mine
control
point
may
effec
tive
reduc
risk
riskdriv
attribut
specif
consid
minim
develop
novel
anti
biotic
